POINT Biopharma Announces Poster Presentation at ESMO
Poster #1400P will be presented on Sunday, September 11 by Dr. Aaron R. ...
Source: globenewswire.com
📰 Initial Results News
Page 4 - Initial Results News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Initial Results. Real-time updates on events, politics, business and more.
POINT Biopharma Announces Poster Presentation at ESMO Congress 2022 Containing Efficacy & Safety Data from Lead-In Cohort of Phase 3 SPLASH Trial
05.09.2022 - Poster #1400P will be presented on Sunday, September 11 by Dr. Aaron R. HansenINDIANAPOLIS, Sept. 04, 2022 (GLOBE NEWSWIRE) - POINT Biopharma Global Inc. (NASDAQ: PNT) (the “Company” or “POINT”), a company accelerating the discovery, development, ... Seite 1
France General Aaronr Hansen University Of Toronto Biopharma Global Inc Specific Membrane Antigen Metastatic Castration Resistant Prostate Cancer
Source: wallstreet-online.de
Investegate |Power Metal Announcements | Power Metal: Tati Gold Project Botswana
Investegate announcements from Power Metal, Tati Gold Project Botswana - Exploration Update
Source: investegate.co.uk
POINT Biopharma to Publish Abstract at ESMO Congress 2022 Containing Efficacy & Safety Data from Lead-In Cohort of Phase 3 SPLASH Trial
18.08.2022 - In advance of the abstract publication, POINT hosted an educational webinar entitled “Understanding the PNT2002 Phase 3 SPLASH Trial Control Arm” Watch the replay at https://hub.pointbiopharma.com/controlarm INDIANAPOLIS, Aug. 18, 2022 (GLOBE ... Seite 1
France General United Kingdom Sherin Al Safadi Kim Chi Oliver Sartor University Of Tulane School Medicine
Source: wallstreet-online.de
POINT Biopharma to Publish Abstract at ESMO Congress 2022 Containing Efficacy & Safety Data from Lead-In Cohort of Phase 3 SPLASH Trial
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
The Arbitration Review of the Americas 2023 - Global Arbitration Review
GAR (Global Arbitration Review) is the world's leading international arbitration journal and news service. GAR provides breaking news, daily updates and in-depth monthly features covering international arbitration in countries around the world. GAR also features guest commentary and articles from the world's leading international arbitration practitioners.
Source: globalarbitrationreview.com
G1 Therapeutics Provides First Quarter 2022 Financial Results and Operational Highlights
G1 Therapeutics Provides First Quarter 2022 Financial Results and Operational Highlights - read this article along with other careers information, tips and advice on BioSpace
United States Rebecca Levine Jen Moses Jack Bailey University Of Illinois Chicago Conference Of The National Comprehensive Cancer Network
Source: biospace.com
Seagen Reports First Quarter 2022 Financial Results
28.04.2022 - Seagen Inc. (Nasdaq:SGEN) reported financial results today for the first quarter ended March 31, 2022. The Company also highlighted PADCEV (enfortumab vedotin-ejfv), TUKYSA (tucatinib), ADCETRIS (brentuximab vedotin) and TIVDAK (tisotumab ...
Source: wallstreet-online.de
Community-led Strategies to Aid Vaccine Acceptance: Five Case Studies from the Global South
"The series of missteps fueling COVID-19 vaccine hesitancy, refusals, and mistrust in health systems has unfortunately spilled over to degrade the progress of previously successful routine immunizations (RI)."
Source: comminit.com
FDA Approves New KYPROLIS® (carfilzomib) Combination Regimen With DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) and dexamethasone For Patients With Multiple Myeloma At First Or Subsequent Relapse
/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved the expansion of the KYPROLIS® (carfilzomib)...
Source: prnewswire.com